Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Avatrombopag manufacturers

4 products found

Filters

4 products found

avatrombopag

Tablets 20 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Daptelet. Patent: EU - 06/2029 - Market exclusivity, US - 07/2027 - Pediatric exclusivity.
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 9 days

avatrombopag

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
TGA, INVIMA, ANVISA, China
Manufacturer #36629

Manufacturer usually replies in nan days

avatrombopag

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36698

Established in 2000, this manufacturer is a CTD dossier owner and manufacturer, focusing on high-quality pharmaceutical drugs for global public health diseases such as HIV and malaria. As a CTD dossier owner and manufacturer, it is dedicated to the research, development, manufacturing, sales, and marketing of these essential medications.

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible